Resveratrol inhibits IL-1β-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro

Annals of the New York Academy of Sciences

Volumn 1095, Issue , 2007, Pages 554-563

  Shakibaei, Mehdi ^a   John, Thilo ^b   Seifarth, Claudia ^a   Mobasheri, Ali ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Apoptosis; Caspase 3; Chondrocyte; IL 1 ; Osteoarthritis; PARP; Resveratrol

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BETA1 INTEGRIN; CASPASE 3; CASPASE INHIBITOR; COLLAGEN TYPE 2; INTERLEUKIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUTRACEUTICAL; RESVERATROL; ANTIOXIDANT; NONSTEROID ANTIINFLAMMATORY AGENT; PARP1 PROTEIN, HUMAN; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CARTILAGE CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; ARTICLE; ARTICULAR CARTILAGE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HYDROLYSIS; METABOLISM; PHYSIOLOGY;

ANIMALIA; VITACEAE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CARTILAGE, ARTICULAR; CASPASE 3; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; ENZYME ACTIVATION; HUMANS; HYDROLYSIS; INTERLEUKIN-1BETA; POLY(ADP-RIBOSE) POLYMERASES; STILBENES;

EID: 34247880271     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.060     Document Type: Conference Paper

References (29)

1. BAOLIN, L., Y. INAMI, H. TANAKA, et al. 2004. Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. Planta Med. 70: 305-309.
2. LEIRO, J., J.A. ARRANZ, A. PARAMA, et al. 2004. In vitro effects of the polyphenols resveratrol, mangiferin and (-)-epigallocatechin-3-gallate on the scutic-ociliate fish pathogen Philasterides dicentrarchi. Dis. Aquat. Organ 59: 171-174.
3. GAUTAM, S.C., Y.X. XU, M. DUMAGUIN, et al. 2000. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant. 25: 639-645.
4. SURH, Y.J., Y.J. HURH, J.Y. KANG, et al. 1999. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140: 1-10.
5. TSAN, M.F., J.E. WHITE, J.G. MAHESHWARI, et al. 2000. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. Br. J. Haematol. 109: 405-412.
6. ESTROV, Z., S. SHISHODIA, S. FADERL, et al. 2003. Resveratrol blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102: 987-995.
7. HSIEH, T.C., G. JUAN, Z. DARZYNKIEWICZ, et al. 1999. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59: 2596-2601.
8. CLEMENT, M.V., J.L. HIRPARA, S.H. CHAWDHURY, et al. 1998. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002.
9. MALEMUD, C.J., N. ISLAM & T.M. HAQQI. 2003. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174: 34-48.
10. BLANCO, G.F.J. 1999. Catabolic events in osteoarthritic cartilage. Osteoarthritis Cartilage 7: 308-309.
11. HASHIMOTO, S., R.L. OCHS, S. KOMIYA, et al. 1998. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum. 41: 1632-1638.
12. AIGNER, T. & H.A. KIM. 2002. Apoptosis and cellular vitality: issues in osteoarthritic cartilage degeneration. Arthritis Rheum. 46: 1986-1996.
13. RATH, P.C. & B.B. AGGARWAL. 1999. TNF-induced signaling in apoptosis. J. Clin. Immunol. 19: 350-364.
14. SHAKIBAEI, M., G. SCHULZE-TANZIL & Y. TAKADA. 2005. Redox regulation of apoptosis by members of the TNF superfamily. Antioxid. Redox. Signal. 7: 482-496.
15. COHEN, G.M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326: 1-16.
16. SHAKIBAEI, M., T. JOHN, P. DE SOUZA, et al. 1999. Signal transduction by β1-integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor. Biochem. J. 342: 615-623.
17. SHAKIBAEI, M. & P. DE SOUZA. 1997. Differentiation of mesenchymal limb bud cells to chondrocytes in alginate beads. Cell. Biol. Int. 21: 75-86.
18. SHAKIBAEI, M., G. SCHULZE-TANZIL, P. DE SOUZA, et al. 2001. Inhibition of mitogen-activated protein kinase induces apoptosis of human chondrocytes. J. Biol. Chem. 276: 13289-13294.
19. SCHULZE-TANZIL, G., P. DE SOUZA, H. VILLEGAS CASTREJON, et al. 2002. Redifferentiation of dedifferentiated human chondrocytes in high-density cultures. Cell Tissue Res. 308: 371-379.
20. GEHM, B.D., J.M. MCANDREWS, P.Y. CHIEN, et al. 1997. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 94: 14138-14143.
21. FERNANDES, J.C., J. MERTEL-PELLETIER & J.P. PELLETIER. 2002. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39: 237-246.
22. LOTEM, J., M. PELEDKAMAR, Y. GRONER, et al. 1996. Cellular oxidative stress and the control of apoptosis by wild-type P53 cytotoxic components and cytokines. Proc. Natl. Acad. Sci. USA 93: 9166-9171.
23. DINARELLO, C.A. 1991. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
24. LO, M.Y. & H.T. KIM. 2004. Chondrocyte apoptosis induced by collagen degradation: inhibition by caspase inhibitors and IGF-1. J. Orthop. Res. 22: 140-144.
25. AGGARWAL, S., S. GOLLAPUDI & S. GUPTA. 1999. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J. Immunol. 162: 2154-2161.
26. MURAKAMI, S., V. LEFEBVRE, B. DECROMBUGGHE, et al. 2000. Potent inhibition of the master chondrogenic factor sox9 gene by interleukin-1 and tumor necrosis factor-α. J. Biol. Chem. 275: 3687-3692.
27. KOLETTAS, E., H.I. MUIR, J.C. BARRETT, et al. 2001. Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of sox-9 transcription factor. Rheumatology 40: 1146-1156.
28. DING, G.J.F., P.A. FISCHER, R.C. BOLTZ, et al. 1998. Characterization and quantitation of NF-κB nuclear translocation induced by interleukin-1 and tumor necrosis factor-α. J. Biol. Chem. 273: 28897-28905.
29. YANG, C., S.W. LI, H.J. HELMINEN, et al. 1997. Apoptosis of chondrocytes in transgenic mice lacking collagen II. Exp. Cell. Res. 235: 370-373.